DD has received research support from Eli Lilly & Co. and AstraZeneca. AD has been a consultant for AstraZeneca and Eli Lilly & Co. PG has been a consultant for Eli Lilly & Co., AstraZeneca and ICN. MM and SS have no reported conflict of interest.
Salivary cortisol secretion in remitted bipolar patients and offspring of bipolar parents
Version of Record online: 18 JUL 2006
Volume 8, Issue 4, pages 345–349, August 2006
How to Cite
Deshauer, D., Duffy, A., Meaney, M., Sharma, S. and Grof, P. (2006), Salivary cortisol secretion in remitted bipolar patients and offspring of bipolar parents. Bipolar Disorders, 8: 345–349. doi: 10.1111/j.1399-5618.2006.00338.x
- Issue online: 18 JUL 2006
- Version of Record online: 18 JUL 2006
- Received 20 May 2004, revised and accepted for publication 1 February 2006
- bipolar disorder;
- cortisol waking response;
- family studies;
Objectives: It is generally believed that cortisol secretion normalizes during clinical remission in mood disorders. However, this assumption has been challenged by preliminary reports of enhanced cortisol secretion in remitted bipolar patients and in the offspring of bipolar parents. The purpose of this study is to replicate findings of increased cortisol secretion during clinical remission in bipolar patients and in the offspring of bipolar parents, rigorously controlling for known confounders.
Methods: We conducted intensive cortisol sampling (six samples per day for three test days, on three consecutive weekends) on 15 bipolar type I and type II patients and 28 unrelated offspring of bipolar parents. Offspring had a history of unipolar depression. Participation was restricted to cases in complete sustained remission. Controls were matched as closely as possible for age, sex, and education. Mood and sleep measures were recorded on each sampling day.
Results: In total, 743 samples were collected from the patient group and 576 from controls. Correcting for repeat measures, there was no statistically significant difference in cortisol secretion at any sampling time between remitted bipolar patients, remitted offspring of bipolar parents, and normal controls. The cortisol waking response did not differ between patients and controls. Covariates, including sex, age, Beck depression score and hours of sleep, were not statistically significant.
Conclusions: Our observations are consistent with the view that complete sustained clinical remission is associated with normal salivary cortisol levels throughout the day. A personal or family history of bipolar disorder per se does not appear to confer added risk for increased salivary cortisol secretion during sustained clinical remission.